BioSig Technologies Inc. (BSGM) - מקדם חוב לטווח ארוך להון

The price history of Biosig Technologies (BSGM) reflects the dynamics of an asset valued at 0.00. Biosig Technologies is currently upgrading its PURE EP platform to expand market reach through alliances by 2026. The business relies on creating a cardiology data analysis ecosystem where integrated software and hardware increase switching costs for clinics. Revenue is also generated by ECG noise suppression and sensor maintenance services.

This ratio determines the extent of the company's dependence on long-term borrowings relative to its equity. Analyzing the long-term capital structure indicator allows for an assessment of financial leverage stability over a horizon exceeding one year. The metric compares the total of "long" loans against the base asset value minus liabilities. For Biosig Technologies (BSGM), this is critical, as current deliveries of PUREEP systems generate a moderate cash flow. The stability of this indicator confirms that previous concerns regarding liquidity deficits have been mitigated.